Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Section 16 reporting ended · disclosed 2025-05-09. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 07, 2025 Filed May 9, 2025 21:30 UTC | OS Therapies Inc OSTX · Entity 6950 | SaleCommon Stock, par value $0.001 per share | 82,000 | $2.00 | $163,918.00 |
DisclosureSEC source: 0001641172-25-009543 · ownership.xml · nonDerivative · entry 1 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 2,664,199 F2 · price: The price reported in Column 4 is a weighted average price. These shares of Comm Stock were sold in multiple transactions at prices ranging from $1.69 to $2.22 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| April 10, 2025 Filed Apr 11, 2025 21:45 UTC | OS Therapies Inc OSTX · Entity 6950 | SaleCommon Stock, par value $0.001 per share | 10,000 | $1.39 | $13,900.00 |
DisclosureSEC source: 0001641172-25-003926 · ownership.xml · nonDerivative · entry 2 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 2,746,199 F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| April 09, 2025 Filed Apr 11, 2025 21:45 UTC | OS Therapies Inc OSTX · Entity 6950 | SaleCommon Stock, par value $0.001 per share | 50,012 | $1.35 | $67,666.24 |
DisclosureSEC source: 0001641172-25-003926 · ownership.xml · nonDerivative · entry 1 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 2,756,199 F2 · price: The price reported in Column 4 is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $1.33 to $1.42 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 16:05 UTC | OS Therapies Inc OSTX · Entity 6950 | OtherCommon Stock, par value $0.001 per share | 225,000 | $1.64 | $369,000.00 |
DisclosureSEC source: 0001493152-25-008695 · ownership.xml · nonDerivative · entry 1 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 2,806,211 F2 · kind: Forfeiture of shares of Common Stock that were held in escrow pursuant to a Transfer Agreement that Einodmil entered into on May 13, 2024. The shares of Common Stock were forfeited pursuant to the terms and conditions of the Transfer Agreement. F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:00 UTC | OS Therapies Inc OSTX · Entity 6950 | SaleCommon Stock, par value $0.001 per share | 100,000 | $2.84 | $284,300.00 |
DisclosureSEC source: 0001493152-25-007236 · ownership.xml · nonDerivative · entry 1 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 2,431,211 F2 · price: The price reported in Column 4 is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $2.67 to $3.036 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:00 UTC | OS Therapies Inc OSTX · Entity 6950 | SaleCommon Stock, par value $0.001 per share | 16,720 | $6.74 | $112,609.20 |
DisclosureSEC source: 0001493152-25-002850 · ownership.xml · nonDerivative · entry 1 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 2,531,211 F2 · price: The price reported in Column 4 is a weighted average price. These shares of Comm Stock were sold in multiple transactions at prices ranging from $6.618 to $6.80 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| August 02, 2024 Filed Jan 14, 2025 20:26 UTC | OS Therapies Inc OSTX · Entity 6950 | ConversionConvertible Promissory Note · Derivative | Not disclosed | $0.00 Strike: $2.00 | $100,000.00 |
DisclosureSEC source: 0001493152-25-002247 · ownership.xml · derivative · entry 24 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 50,838 shares Expires 2024-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $100,000 at a conversion price of $2.00 per share. F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| August 02, 2024 Filed Jan 14, 2025 20:26 UTC | OS Therapies Inc OSTX · Entity 6950 | ConversionConvertible Promissory Note · Derivative | Not disclosed | $0.00 Strike: $2.00 | $350,000.00 |
DisclosureSEC source: 0001493152-25-002247 · ownership.xml · derivative · entry 23 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 178,135 shares Expires 2024-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $350,000 at a conversion price of $2.00 per share. F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| August 02, 2024 Filed Jan 14, 2025 20:26 UTC | OS Therapies Inc OSTX · Entity 6950 | ConversionConvertible Promissory Note · Derivative | Not disclosed | $0.00 Strike: $2.00 | $100,000.00 |
DisclosureSEC source: 0001493152-25-002247 · ownership.xml · derivative · entry 22 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 51,035 shares Expires 2024-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $100,000 at a conversion price of $2.00 per share. F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| August 02, 2024 Filed Jan 14, 2025 20:26 UTC | OS Therapies Inc OSTX · Entity 6950 | ConversionConvertible Promissory Note · Derivative | Not disclosed | $0.00 Strike: $2.00 | $350,000.00 |
DisclosureSEC source: 0001493152-25-002247 · ownership.xml · derivative · entry 21 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 179,027 shares Expires 2024-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $350,000 at a conversion price of $2.00 per share. F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| August 02, 2024 Filed Jan 14, 2025 20:26 UTC | OS Therapies Inc OSTX · Entity 6950 | ConversionConvertible Promissory Note · Derivative | Not disclosed | $0.00 Strike: $2.00 | $170,000.00 |
DisclosureSEC source: 0001493152-25-002247 · ownership.xml · derivative · entry 20 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 88,940 shares Expires 2024-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $170,000 at a conversion price of $2.00 per share. F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| August 02, 2024 Filed Jan 14, 2025 20:26 UTC | OS Therapies Inc OSTX · Entity 6950 | ConversionConvertible Promissory Note · Derivative | Not disclosed | $0.00 Strike: $2.00 | $150,000.00 |
DisclosureSEC source: 0001493152-25-002247 · ownership.xml · derivative · entry 19 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 78,710 shares Expires 2024-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $150,000 at a conversion price of $2.00 per share. F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| August 02, 2024 Filed Jan 14, 2025 20:26 UTC | OS Therapies Inc OSTX · Entity 6950 | ConversionConvertible Promissory Note · Derivative | Not disclosed | $0.00 Strike: $2.00 | $250,000.00 |
DisclosureSEC source: 0001493152-25-002247 · ownership.xml · derivative · entry 18 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 131,472 shares Expires 2024-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $250,000 at a conversion price of $2.00 per share. F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| August 02, 2024 Filed Jan 14, 2025 20:26 UTC | OS Therapies Inc OSTX · Entity 6950 | ConversionConvertible Promissory Note · Derivative | Not disclosed | $0.00 Strike: $2.00 | $100,000.00 |
DisclosureSEC source: 0001493152-25-002247 · ownership.xml · derivative · entry 17 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 53,468 shares Expires 2024-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $100,000 at a conversion price of $2.00 per share. F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| August 02, 2024 Filed Jan 14, 2025 20:26 UTC | OS Therapies Inc OSTX · Entity 6950 | ConversionConvertible Promissory Note · Derivative | Not disclosed | $0.00 Strike: $2.00 | $500,000.00 |
DisclosureSEC source: 0001493152-25-002247 · ownership.xml · derivative · entry 16 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 270,465 shares Expires 2024-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $500,000 at a conversion price of $2.00 per share. F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| August 02, 2024 Filed Jan 14, 2025 20:26 UTC | OS Therapies Inc OSTX · Entity 6950 | ConversionConvertible Promissory Note · Derivative | Not disclosed | $0.00 Strike: $2.00 | $50,000.00 |
DisclosureSEC source: 0001493152-25-002247 · ownership.xml · derivative · entry 15 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 27,486 shares Expires 2024-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $50,000 at a conversion price of $2.00 per share. F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| August 02, 2024 Filed Jan 14, 2025 20:26 UTC | OS Therapies Inc OSTX · Entity 6950 | ConversionConvertible Promissory Note · Derivative | Not disclosed | $0.00 Strike: $2.00 | $1,150,000.00 |
DisclosureSEC source: 0001493152-25-002247 · ownership.xml · derivative · entry 14 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 633,980 shares Expires 2024-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $1,150,000 at a conversion price of $2.00 per share. F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| August 02, 2024 Filed Jan 14, 2025 20:26 UTC | OS Therapies Inc OSTX · Entity 6950 | ConversionConvertible Promissory Note · Derivative | Not disclosed | $0.00 Strike: $1.31 | $25,000.00 |
DisclosureSEC source: 0001493152-25-002247 · ownership.xml · derivative · entry 13 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,371 shares Expires 2024-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Mr. Auerbach in the principal amount of $25,000 at a conversion price of $1.31 per share. Read SEC document |
| August 02, 2024 Filed Jan 14, 2025 20:26 UTC | OS Therapies Inc OSTX · Entity 6950 | ConversionCommon Stock, par value $0.001 per share | 50,838 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-25-002247 · ownership.xml · nonDerivative · entry 12 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 2,547,931 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · price: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $100,000 at a conversion price of $2.00 per share. F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| August 02, 2024 Filed Jan 14, 2025 20:26 UTC | OS Therapies Inc OSTX · Entity 6950 | ConversionCommon Stock, par value $0.001 per share | 178,135 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-25-002247 · ownership.xml · nonDerivative · entry 11 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 2,497,093 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · price: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $350,000 at a conversion price of $2.00 per share. F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| August 02, 2024 Filed Jan 14, 2025 20:26 UTC | OS Therapies Inc OSTX · Entity 6950 | ConversionCommon Stock, par value $0.001 per share | 51,035 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-25-002247 · ownership.xml · nonDerivative · entry 10 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 2,318,958 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · price: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $100,000 at a conversion price of $2.00 per share. F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| August 02, 2024 Filed Jan 14, 2025 20:26 UTC | OS Therapies Inc OSTX · Entity 6950 | ConversionCommon Stock, par value $0.001 per share | 179,027 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-25-002247 · ownership.xml · nonDerivative · entry 9 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 2,267,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · price: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $350,000 at a conversion price of $2.00 per share. F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| August 02, 2024 Filed Jan 14, 2025 20:26 UTC | OS Therapies Inc OSTX · Entity 6950 | ConversionCommon Stock, par value $0.001 per share | 88,940 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-25-002247 · ownership.xml · nonDerivative · entry 8 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 2,088,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · price: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $170,000 at a conversion price of $2.00 per share. F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| August 02, 2024 Filed Jan 14, 2025 20:26 UTC | OS Therapies Inc OSTX · Entity 6950 | ConversionCommon Stock, par value $0.001 per share | 78,710 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-25-002247 · ownership.xml · nonDerivative · entry 7 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 1,999,956 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $150,000 at a conversion price of $2.00 per share. F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| August 02, 2024 Filed Jan 14, 2025 20:26 UTC | OS Therapies Inc OSTX · Entity 6950 | ConversionCommon Stock, par value $0.001 per share | 131,472 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-25-002247 · ownership.xml · nonDerivative · entry 6 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 1,921,246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · price: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $250,000 at a conversion price of $2.00 per share. F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| August 02, 2024 Filed Jan 14, 2025 20:26 UTC | OS Therapies Inc OSTX · Entity 6950 | ConversionCommon Stock, par value $0.001 per share | 53,468 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-25-002247 · ownership.xml · nonDerivative · entry 5 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 1,789,774 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $100,000 at a conversion price of $2.00 per share. F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| August 02, 2024 Filed Jan 14, 2025 20:26 UTC | OS Therapies Inc OSTX · Entity 6950 | ConversionCommon Stock, par value $0.001 per share | 270,465 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-25-002247 · ownership.xml · nonDerivative · entry 4 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 1,736,306 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $500,000 at a conversion price of $2.00 per share. F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| August 02, 2024 Filed Jan 14, 2025 20:26 UTC | OS Therapies Inc OSTX · Entity 6950 | ConversionCommon Stock, par value $0.001 per share | 27,486 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-25-002247 · ownership.xml · nonDerivative · entry 3 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 1,465,841 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $50,000 at a conversion price of $2.00 per share. F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| August 02, 2024 Filed Jan 14, 2025 20:26 UTC | OS Therapies Inc OSTX · Entity 6950 | ConversionCommon Stock, par value $0.001 per share | 633,980 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-25-002247 · ownership.xml · nonDerivative · entry 2 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 1,438,355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $1,150,000 at a conversion price of $2.00 per share. F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| August 02, 2024 Filed Jan 14, 2025 20:26 UTC | OS Therapies Inc OSTX · Entity 6950 | ConversionCommon Stock, par value $0.001 per share | 23,371 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-25-002247 · ownership.xml · nonDerivative · entry 1 Auerbach Shalom · CIK 0002048828 · 10% owner Einodmil LLC · CIK 0002048829 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,371 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Mr. Auerbach in the principal amount of $25,000 at a conversion price of $1.31 per share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.